NO892441L - Kolestadienderivater, fremgangsmaate for fremstilling derav samt anvendelse derav som legemiddel med hmg-coa-reduktase-hemmende virkning. - Google Patents

Kolestadienderivater, fremgangsmaate for fremstilling derav samt anvendelse derav som legemiddel med hmg-coa-reduktase-hemmende virkning.

Info

Publication number
NO892441L
NO892441L NO89892441A NO892441A NO892441L NO 892441 L NO892441 L NO 892441L NO 89892441 A NO89892441 A NO 89892441A NO 892441 A NO892441 A NO 892441A NO 892441 L NO892441 L NO 892441L
Authority
NO
Norway
Prior art keywords
mol
formula
solution
cholesterol
hmg
Prior art date
Application number
NO89892441A
Other languages
English (en)
Norwegian (no)
Other versions
NO892441D0 (no
Inventor
Wolfgang Hermann Kreiser
Peter Scharein
Ernold Granzer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO892441D0 publication Critical patent/NO892441D0/no
Publication of NO892441L publication Critical patent/NO892441L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO89892441A 1988-06-14 1989-06-13 Kolestadienderivater, fremgangsmaate for fremstilling derav samt anvendelse derav som legemiddel med hmg-coa-reduktase-hemmende virkning. NO892441L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3820177A DE3820177A1 (de) 1988-06-14 1988-06-14 Cholestadienderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel mit hmg-coa-reduktase-hemmender wirkung

Publications (2)

Publication Number Publication Date
NO892441D0 NO892441D0 (no) 1989-06-13
NO892441L true NO892441L (no) 1989-12-15

Family

ID=6356493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89892441A NO892441L (no) 1988-06-14 1989-06-13 Kolestadienderivater, fremgangsmaate for fremstilling derav samt anvendelse derav som legemiddel med hmg-coa-reduktase-hemmende virkning.

Country Status (11)

Country Link
EP (1) EP0346759A3 (da)
JP (1) JPH0236192A (da)
KR (1) KR910000786A (da)
AU (1) AU3629189A (da)
DE (1) DE3820177A1 (da)
DK (1) DK288989A (da)
FI (1) FI892867L (da)
IL (1) IL90572A0 (da)
NO (1) NO892441L (da)
PT (1) PT90843A (da)
ZA (1) ZA894469B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200066690A (ko) 2017-10-16 2020-06-10 칭화대학교 메발로네이트 경로 억제제 및 이의 약제학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107188A (en) * 1977-04-22 1978-08-15 Hoffmann-La Roche Inc. Pregnanes

Also Published As

Publication number Publication date
DE3820177A1 (de) 1989-12-21
EP0346759A3 (de) 1990-01-31
FI892867A7 (fi) 1989-12-15
JPH0236192A (ja) 1990-02-06
AU3629189A (en) 1989-12-21
IL90572A0 (en) 1990-01-18
DK288989D0 (da) 1989-06-13
KR910000786A (ko) 1991-01-30
DK288989A (da) 1989-12-15
ZA894469B (en) 1990-02-28
EP0346759A2 (de) 1989-12-20
FI892867A0 (fi) 1989-06-12
PT90843A (pt) 1989-12-29
FI892867L (fi) 1989-12-15
NO892441D0 (no) 1989-06-13

Similar Documents

Publication Publication Date Title
FI87792B (fi) Tigogenin-cellubiosid-okta-acetat
NO303450B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive gallesyrederivater
US3822254A (en) Synthesis of 25-hydroxycholesterol
GB1599863A (en) Pharmaceutical compositions for use in the inhibition of the biosynthesis of mevalonic acid
EP0071153B1 (de) Neue Androstan-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten
US4585791A (en) Furyl derivatives of 16-substituted prostaglandins
NO140978B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
US4226770A (en) Synthesis of steroids
FI70720C (fi) Foerfarande foer framstaellning av 17beta-hydroxi-17alfa-pregn-5-en-21-karboxylsyra-ny-laktoner
US3984455A (en) Prostaglandin E1 analogs
NO892441L (no) Kolestadienderivater, fremgangsmaate for fremstilling derav samt anvendelse derav som legemiddel med hmg-coa-reduktase-hemmende virkning.
JPH06166681A (ja) キナ酸誘導体およびその製造方法
TWI710550B (zh) 魯比前列酮(lubiprostone)之製備方法及其中間物
AU4797093A (en) Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them
US4217279A (en) Synthesis of steroids
Byon et al. The C-25 chirality of 26-hydroxycholesterol
SU826957A3 (ru) Способ получения 11[ь-окси-18-метилстероидов' эстранового ряда .
US4163744A (en) Synthesis of steroids
HU208152B (en) Process for producing 19-norprogesterone derivatives alkylated in 17/21-position and pharmaceutical compositions comprising such compounds
GB2102003A (en) New 11 beta ,18-epoxy steroids having anti-aldosterone activity
US3661941A (en) Process for preparation of 3beta-hydroxy a/b cis steroids of the cholestane series
SU1001860A3 (ru) Способ получени производных хлорамбуцила (его варианты)
JPS62207236A (ja) フエノキシアルカン酸誘導体
US3639388A (en) Tridesoxypyranosides and process for their manufacture
US3985771A (en) Total steroid synthesis employing substituted isoxazole derivatives